Strongyloidiasis

13 registered clinical trials studyying Strongyloidiasis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Better Options for Lymphatic Filariasis Treatment NCT07159373	Medicines Development for Global Health	Phase 3
Completed	Strongyloidiasis at CHRU Nancy: Evaluation of the Performance of Serological Tests and Disease-associated Char NCT07296198	Central Hospital, Nancy, France	—
Completed	Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis NCT06373835	Swiss Tropical & Public Health Institute	Phase 2
Completed	Delivering a Multi-disease Screening Tool to Migrant Populations NCT05868005	Barcelona Institute for Global Health	N/A
Completed	Evaluation of Strongyloidiasis in Ecuador: a fieLd Laboratory Accuracy Study NCT04999774	IRCCS Sacro Cuore Don Calabria di Negrar	—
Unknown	Adjunctive Ivermectin Mass Drug Administration for Malaria Control NCT04844905	London School of Hygiene and Tropical Medicine	Phase 3
Unknown	Strongyloides Stercoralis in Bone Marrow Transplant Recipients in the UK NCT04709848	Imperial College Healthcare NHS Trust	—
Completed	Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) NCT03676140	Lihir Medical Centre	Phase 3
Completed	Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders NCT02105714	Swiss Tropical & Public Health Institute	—
Completed	Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis NCT01570504	Centro per le Malattie Tropicali	Phase 3
Terminated	Treatment of Strongyloides Infection NCT03605758	Albert Einstein College of Medicine	Phase 3
Completed	Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections NCT00207753	Centers for Disease Control and Prevention	N/A
Completed	Study of Patients With Strongyloides Stercoralis Infection NCT00001245	National Institute of Allergy and Infectious Diseases (NIAID)	—